---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-090625"
form_type: "8-K"
ticker: "TNON"
cik: "0001560293"
company_name: "Tenon Medical, Inc."
filed_at: "2023-11-28T23:59:59+00:00"
generated_at: "2026-06-07T21:01:10.180604+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Tenon Medical raises $1.125M net via 10% secured notes and warrants

## Summary
- Sold $1.25M in secured notes (10% interest, due Nov 21, 2024) with warrants for 45,000 shares at $1.94.
- Net proceeds of $1.125M after investor expenses; notes secured by first-priority lien on all assets.
- Warrants exercisable immediately for five years, include cashless exercise and anti-dilution provisions.
- Proceeds to be used for working capital and general corporate purposes.

## SEC filing metadata
- accession: 0001213900-23-090625
- form_type: 8-K
- ticker: TNON
- cik: 0001560293
- company_name: Tenon Medical, Inc.
- filed_at: 2023-11-28T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1560293/000121390023090625/0001213900-23-090625-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1560293/000121390023090625/ea189166-8k_tenonmed.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-090625
- JSON: https://secwatch.observer/filing/0001213900-23-090625.json
- Plain text: https://secwatch.observer/filing/0001213900-23-090625.txt

## Key facts
- Material Agreements
  Tenon Medical, Inc. entered into Securities Purchase Agreements with certain investors valued at $1,250,000 (effective 2023-11-21).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain investors
  - Value: $1,250,000
  - Effective: 2023-11-21
  source text: On November 21, 2023, Tenon Medical, Inc. (the “Company”) entered into Securities Purchase Agreements (the “Purchase Agreements”) with certain investors (the “Investors”), pursuant to which the Company agreed to sell, issue and deliver to the Investors, in a private placement offering (the “Offering”), a total of $1,250,000 in secured notes (the “Notes”) and warrants (the “Warrants”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1560293/000121390023090625/0001213900-23-090625-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
